Archive · 19 May 2025
FDA Approves First Blood Test for Early Alzheimer's Detection
Imagine a new way to find out if someone has Alzheimer's, a disease that affects the brain.
The FDA has approved a blood test for this.
The test looks for special proteins that can build up in the brain of people with Alzheimer’s.
This new blood test can help doctors find the disease earlier than before, instead of having to do expensive brain scans.
Finding out earlier means people can start treatment sooner, which might help slow down the disease.
The FDA has approved the first blood test to help detect Alzheimer's disease.
The test measures amyloid and tau proteins in the blood.
The test is for patients already showing signs of cognitive decline.
The test is meant to be used in clinical settings.
Earlier diagnosis could lead to earlier treatment and better outcomes.
- Who
- The US FDA
- What
- The FDA approved the first blood test to detect Alzheimer's disease.
- When
- Announced on Friday, May 19, 2025
- Where
- United States
- Why
- To allow for earlier diagnosis and treatment of Alzheimer's disease.
- Test Purpose
- Detect Alzheimer's disease
- Approval Agency
- US Food and Drug Administration (FDA)
- Method
- Blood test measuring amyloid and tau proteins
- Target Population
- Patients showing cognitive decline
- Accuracy
- 92% accuracy in detecting the disease